Baum RP - Search Results

1

Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT.

Prasad V, Ambrosini V, Hommann M, Hoersch D, Fanti S, Baum RP. Prasad V, et al. Among authors: baum rp. Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):67-77. doi: 10.1007/s00259-009-1205-y. Eur J Nucl Med Mol Imaging. 2010. PMID: 19618183

2

Human monoclonal antibody 99mTc-88BV59: detection of colorectal cancer, recurrent or metastatic disease and immunogenicity assessment.

Krause BJ, Baum RP, Staib-Sebler E, Lorenz M, Niesen A, Hör G. Krause BJ, et al. Among authors: baum rp. Eur J Nucl Med. 1997 Jan;24(1):72-5. doi: 10.1007/BF01728312. Eur J Nucl Med. 1997. PMID: 9044881

3

Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours.

Adams S, Baum R, Rink T, Schumm-Dräger PM, Usadel KH, Hör G. Adams S, et al. Eur J Nucl Med. 1998 Jan;25(1):79-83. doi: 10.1007/s002590050197. Eur J Nucl Med. 1998. PMID: 9396878 Clinical Trial.

4

Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer.

Adams S, Baum RP, Stuckensen T, Bitter K, Hör G. Adams S, et al. Among authors: baum rp. Eur J Nucl Med. 1998 Sep;25(9):1255-60. doi: 10.1007/s002590050293. Eur J Nucl Med. 1998. PMID: 9724374

5

Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings.

Adams S, Baum RP, Hertel A, Schumm-Draeger PM, Usadel KH, Hör G. Adams S, et al. Among authors: baum rp. Eur J Nucl Med. 1998 Sep;25(9):1277-83. doi: 10.1007/s002590050296. Eur J Nucl Med. 1998. PMID: 9724377

6

Metabolic (PET) and receptor (SPET) imaging of well- and less well-differentiated tumours: comparison with the expression of the Ki-67 antigen.

Adams S, Baum RP, Hertel A, Schumm-Dräger PM, Usadel KH, Hör G. Adams S, et al. Among authors: baum rp. Nucl Med Commun. 1998 Jul;19(7):641-7. doi: 10.1097/00006231-199807000-00005. Nucl Med Commun. 1998. PMID: 9853344 Clinical Trial.

7

PET with 2-[F-18]-fluoro-2-deoxy-D-glucose (FDG) in patients with cancer of unknown primary (CUP): influence on patients' diagnostic and therapeutic management.

Mantaka P, Baum RP, Hertel A, Adams S, Niessen A, Sengupta S, Hör G. Mantaka P, et al. Among authors: baum rp. Cancer Biother Radiopharm. 2003 Feb;18(1):47-58. doi: 10.1089/108497803321269322. Cancer Biother Radiopharm. 2003. PMID: 12667308

8

Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancer.

Baum RP, Hellwig D, Mezzetti M. Baum RP, et al. Q J Nucl Med Mol Imaging. 2004 Jun;48(2):119-42. Q J Nucl Med Mol Imaging. 2004. PMID: 15243408 Free article. Review.

9

Imaging of neuroendocrine tumors.

Rufini V, Calcagni ML, Baum RP. Rufini V, et al. Among authors: baum rp. Semin Nucl Med. 2006 Jul;36(3):228-47. doi: 10.1053/j.semnuclmed.2006.03.007. Semin Nucl Med. 2006. PMID: 16762613 Review.

10

Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?

Antunes P, Ginj M, Zhang H, Waser B, Baum RP, Reubi JC, Maecke H. Antunes P, et al. Among authors: baum rp. Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):982-93. doi: 10.1007/s00259-006-0317-x. Epub 2007 Jan 16. Eur J Nucl Med Mol Imaging. 2007. PMID: 17225119 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters